EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)

Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trial

Sylvia Mechsner, Jackie Grünert, Jakob Johann Wiese, Jane Vormbäumen iD, Jalid Sehouli, Britta Siegmund iD, Lars Neeb, Magdalena Sarah Prüß iD

Pain Medicine · 05.07.2023 · 24 (7) · 809-817

DOI: 10.1093/pm/pnad031 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pain Medicine, online erschienen am 06.03.2023. Verfasst von Sylvia Mechsner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berli…. Hauptthemen laut MEDLINE: Transcranial Direct Current Stimulation, Chronic Pain, Endometriosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: BIH Charité Clinician Scientist, Charité–Universitätsmedizin Berlin, Berlin Institute of Health at Charité.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is known that various chronic pain conditions lead to maladaptive changes in the central nervous system. Endometriosis is frequently associated with chronic pelvic pain (CPP). Its sufficient treatment remains a clinical challenge. Transcranial direct current stimulation (tDCS) has been shown to be a powerful method to reduce chronic pain. Therefore, this study aimed to investigate pain reduction via anodal tDCS in patients with endometriosis and CPP.

Methods

This clinical phase II, placebo-controlled, randomized, parallel-design study included 36 patients with endometriosis and CPP. All patients had CPP, defined as a score of ≥3/10 on the visual analog scale for ≥3 months in the prior 6 months. Anodal or placebo tDCS (18 patients per arm) was applied over the primary motor cortex for 10 days. The primary outcome measure was the pressure pain threshold (objective pain measure), and secondary outcomes were the numerical rating scale score (subjective pain measure), Von Frey monofilaments, and disease- and pain-related questionnaires. Data were collected at baseline, after the 10-day stimulation, and at a follow-up session, which took place 1 week after the tDCS had ended. Statistical analyses were performed with analyses of variance and t tests.

Results

Significant decreased pain perception in both pain measurements (pressure pain threshold and numerical rating scale score) was found for the active tDCS group compared with the placebo group. This proof-of-concept study shows that tDCS is a helpful supporting pain therapy for patients with endometriosis and CPP. Moreover, further analyses revealed that 1 week after the stimulation had ended, pain reduction as indexed by pressure pain threshold remained significantly decreased, which indicates possible long-term analgesic effects.

Conclusion

The present study provides evidence that tDCS is an effective therapy for pain reduction in endometriosis-associated CPP. The results support the notion that CPP is developed and maintained in the central nervous system, making a multimodal pain therapy necessary. Trial registration www.ClinicalTrials.gov ID: NCT05231239.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcranial Direct Current StimulationChronic PainEndometriosisFemaleHumansChronic DiseaseDouble-Blind MethodPelvic Pain

Stichwörter der Autor:innen

chronic painchronic pelvic painendometriosispaintDCStranscranial direct current stimulation

Autor:innen und Institutionen

  • Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.
  • Medizinische Klinik m. S. Gastroenterologie, Infektiologie und Rheumatologie, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Hea…
  • Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Digital Hospital, Helios Global Health, Berlin, Germany.
  • Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin 10178, Germany.
  • Department of Psychology, MSB Medical School Berlin, Berlin 14197, Germany.

ORCID-Profile: Jane Vormbäumen, Britta Siegmund, Magdalena Sarah Prüß

Förderung

  • BIH Charité Clinician Scientist
  • Charité–Universitätsmedizin Berlin
  • Berlin Institute of Health at Charité
  • Gefördert durch die Deutsche For- schungsgemeinschaft
  • Deutsche Forschungsgemeinschaft
  • German Research Foundation

Zitieren

APA

Mechsner, S., Grünert, J., Wiese, J. J., Vormbäumen, J., Sehouli, J., Siegmund, B., Neeb, L., & Prüß, M. S. (2023). Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trial. Pain Medicine, 24(7), 809-817. https://doi.org/10.1093/pm/pnad031

Vancouver

Mechsner S, Grünert J, Wiese JJ, Vormbäumen J, Sehouli J, Siegmund B, et al. Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trial. Pain Medicine. 2023;24(7):809-817. doi:10.1093/pm/pnad031

BibTeX
@article{Mechsner2023,
  author = {Mechsner, Sylvia and Grünert, Jackie and Wiese, Jakob Johann and Vormbäumen, Jane and Sehouli, Jalid and Siegmund, Britta and Neeb, Lars and Prüß, Magdalena Sarah},
  title = {Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trial},
  journal = {Pain Medicine},
  year = {2023},
  volume = {24},
  number = {7},
  pages = {809--817},
  doi = {10.1093/pm/pnad031}
}
Kostenlos starten →